Pixel-Level Spectral Filtering for Non-Invasive Glucose Sensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for blood glucose testing in diabetes are invasive, painful, and require complex equipment, limiting real-time monitoring and increasing infection risk, while existing non-invasive methods are bulky and expensive.

Innovation Solution

A system for analyte spectral collection using a shell with an imaging spectrum detection apparatus and periodic pixel-level light filtering structure, integrated into a portable device, performs spectral modulation to obtain spectral data from the skin without invasive electrochemical reactions, utilizing fluorescence spectroscopy for non-invasive testing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional invasive testing methods (venous blood test or fingerstick blood test) are used, then testing accuracy is ensured, but patient comfort deteriorates and infection risk increases

Engineering Contradiction:
Improvetesting accuracyVSAvoidpatient pain and infection risk
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical invasive testing system (needles, lancets, blood collection tubes) with an optical detection system that uses light to measure glucose concentration through skin tissue. The optical system includes light sources emitting at multiple wavelengths, detectors that measure light absorption or scattering, and processing units that calculate glucose levels from the optical signals, thereby eliminating physical penetration of the skin barrier.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces skin tissue as an intermediary medium between the testing system and the blood glucose. Instead of directly accessing blood, the system shines light through the skin, which acts as a medium that allows optical detection of glucose molecules in underlying blood vessels. This intermediary approach enables indirect measurement without breaking the skin barrier.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If existing non-invasive testing methods are used, then patient comfort is improved, but device complexity and cost increase

Engineering Contradiction:
Improvepatient comfortVSAvoidequipment complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent segments the optical detection system into multiple independent wavelength channels, each targeting specific glucose absorption peaks. By dividing the spectrum into discrete wavelength bands (e.g., 800-1000nm, 1000-1200nm, 1200-1400nm), the system can use simpler detectors for each band rather than requiring a single complex broadband detector, thereby reducing overall system complexity while maintaining non-invasive operation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the operational parameters of the light sources to emit at specific wavelengths corresponding to glucose absorption peaks. By tuning the light sources to fixed, optimized wavelengths rather than using broadband illumination, the system simplifies the detection requirements and reduces the complexity of spectral analysis algorithms, making the non-invasive device more practical and cost-effective.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If existing non-invasive testing methods are used, then patient comfort is improved, but real-time monitoring capability deteriorates

Engineering Contradiction:
Improvepatient comfortVSAvoidreal-time monitoring capability
Core Design Contradiction:
Object-affected harmful factorsVSSpeed

Solution Approach 1:

The patent implements continuous illumination of the skin tissue with multiple wavelength light sources, allowing for uninterrupted optical measurements. The system continuously detects changes in light absorption as glucose levels fluctuate, enabling real-time monitoring. The continuous operation of the optical path without mechanical intervention or sample preparation delays ensures that glucose concentration changes are captured immediately as they occur in the bloodstream.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables simple, low-cost, and real-time non-invasive testing of blood glucose by analyzing uneven spectral distributions, providing accurate glucose concentration measurements without piercing the skin, improving patient comfort and convenience.

Implementation Method 1

the periodic pixel-level light filtering structure performs spectral modulation on an incoming light signal

Methodology Applied
Scientific EffectSpectral modulation:

Implementation Method 2

the imaging spectrum detection apparatus obtains a light signal from the imaging area, the imaging spectrum detection apparatus includes a sensor

Methodology Applied
Scientific EffectPhotoelectric detection: Photoelectric Effect

Implementation Method 3

utilizing fluorescence spectroscopy for non-invasive testing

Methodology Applied
Scientific EffectFluorescence spectroscopy: Fluorescence

Implementation Method 4

The light filtering image element channels with pixel-level light filtering structures of different shapes correspond to different spectral filter coefficients

Methodology Applied
Scientific EffectOptical filtering: Filter (optical)

Data Source

PatentUS20260023022A1System for analyte spectral collection and system for testing analyte
Publication Date: 2026.01.22 SENSURA PTE LTD
  • US20260023022A1 patent drawing
  • US20260023022A1 patent drawing
  • US20260023022A1 patent drawing

AI summary

The present invention provides a system for analyte spectral collection and a system for testing an analyte, and the system for analyte spectral collection, which relate to the field of optical analysis. The system for analyte spectral collection includes a shell and an imaging spectrum detection apparatus. The apparatus obtains a light signal in an imaging area, and includes a sensor and a periodic pixel-level light filtering structure, disposed on a surface of the sensor. The filtering structure performs spectral modulation on an incoming light signal, and the sensor generates an image containing spectral information to be tested. In this application, the periodic pixel-level light filtering structure disposed on the surface of the sensor performs spectral modulation on the incoming light signal, so that the sensor generates an image containing spectral information to be tested, helping analyte spectral collection be performed more simply.